(Its CEO says it is an advocacy organization, not a scientific one.) But the group argues the public would be safer if peptides were handled by regulated compounding pharmacies instead of the gray market
A big commercial-coverage change just landed The biggest pricing news since this post went up is the CVS Caremark announcement on May 28, 2026
They typically provide clear information about product use, proper handling, and realistic expectations
In a 2025 study published in Obesity Medicine , 52% of patients who discontinued GLP-1 therapy cited adverse effects as the main reason
This minimally invasive procedure tightens sagging skin, improves facial contours, and offers natural-looking results with minimal downtime
29 participants (4%) withdrew from the trial entirely [5]